This highly valuable manuscript identifies Metabolic Brain Cell Disease Type Basal Ganglia (MBCD-BG) as the elusive culprit behind alcoholism, proposes treatment and presents the first clinical study of this disease using the FiX-Zy Oil. Dr. Roger Hershline PHD MD, discoverer of MBCD-BG, inventor of the FiX-Zy OiL and founder of Global Humanceuticals Inc. presents valuable insights into what the future treatment of alcoholism should be and will be...